Skip to content
August 14, 2022

Equity.Guru

Investment information for the new generation

MDP.V

Medexus Pharmaceuticals (MDP.V) announced that they’re making their Triamcinolone Hexacetonide (TH) Injectable Suspension, USP (20 mg/ml) available in the United States through the FDA’s CDER Drug Shortage program in…